Early Fostamatinib Use Shows High Response Rates in Immune Thrombocytopenia
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
A nationwide Spanish real-world study of 72 adults with immune thrombocytopenia found that fostamatinib, an oral spleen tyrosine kinase inhibitor, ...
A retrospective study of 16 Chinese children with persistent or chronic immune thrombocytopenia finds that romiplostim is safe but provides ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine